CSNK1A1CK1α-HiBiT HEK293 LgBiT stable cells weretransfected with a HaloTag-CRBN vector (Promega, Cat. #N269A) using
Fugene HD (Promega, Cat. #E2311). Following overnight incubation, cells were replated in OptiMEM I Reduced Serum Medium, no phenol red (Gibco, Cat. #11058021) supplemented with 4% FBS, and
HaloTag 618 ligand (Promega, Cat. #G9801). Plates were incubated overnight at 37 °C with 5% CO
2. On day 3, a dose–response curve was generated by performing 3-fold dilutions of each compound including a DMSO-only control in OptiMEM I Reduced Serum Medium, no phenol red supplemented with 4% FBS. Cells were treated with
MG132 (Selleckchem, Cat. #S2619) for 30 min before being treated with the dilution series of compounds. Plates were incubated for 2 h at 37 °C with 5% CO
2. After 2 h, plates were read using
NanoBRET Nano-Glo substrate (Promega #N1573) on a GloMax Discover following the manufacturer’s instructions. No ligand controls were subtracted from each sample and normalized to the no compound DMSO control to obtain Fractional BRET values. EC
50 values were calculated for each compound curve.
Nishiguchi G., Mascibroda L.G., Young S.M., Caine E.A., Abdelhamed S., Kooijman J.J., Miller D.J., Das S., McGowan K., Mayasundari A., Shi Z., Barajas J.M., Hiltenbrand R., Aggarwal A., Chang Y., Mishra V., Narina S., Thomas M., Loughran A.J., Kalathur R., Yu K., Zhou S., Wang X., High A.A., Peng J., Pruett-Miller S.M., Daniels D.L., Urh M., Shelat A.A., Mullighan C.G., Riching K.M., Zaman G.J., Fischer M., Klco J.M, & Rankovic Z. (2024). Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines. Nature Communications, 15, 482.